Linde
LIN Nasdaq Industrial Gases Financials FY2016–FY2025
Linde's revenue rose 3.0% to $34.0 billion in fiscal 2025. Its operating margin was 26.2%, up from 26.2% a year earlier. Free cash flow was $5.1 billion, up 3.3%. It paid out $7.4 billion in dividends and buybacks, 146% of free cash flow. The diluted share count fell 2.0%.
What Linde does
Linde makes and sells industrial gases and the equipment and services that go with them. It says it is the largest industrial gas company worldwide. Its main products are the gases in air (oxygen, nitrogen, argon and rare gases) and process gases such as hydrogen, helium, carbon dioxide and specialty gases. Customers are in health care, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics. Linde is an Irish company with principal offices in the United Kingdom and the United States.
Linde delivers gases in three ways. On-site supply sends gas by pipeline from a plant next to a large customer. Merchant supply delivers liquid gas in bulk, usually under three- to seven-year contracts. Packaged supply fills metal cylinders for customers who need small amounts. The company picks the method that meets a customer's needs at the lowest cost.
Linde also has an engineering business that designs and builds plants for air separation, hydrogen, synthesis gas, olefins and natural gas. Its sales were $33,986 million in 2025, and approximately 64% of them were outside the United States. At the end of 2025 it had 65,177 employees worldwide.
- Legal name
- Linde plc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 25, 2026
- Accession · CIK
- 0001628280-26-011430
0001707925
Revenue and margins
Linde had $34.0B of revenue in fiscal 2025, up 3.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 12.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $5.1B in fiscal 2025, 15.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Linde returned $7.4B to shareholders in fiscal 2025, 146% of free cash flow. The diluted share count fell 2.1%.
Value Linde yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$22.1B and divides by 472.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today 32.8x · peers 20.6x · sector 20.1x.
Balance sheet
Cash, debt and the ratios that show how comfortably Linde can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.8B | $5.4B | $4.7B | $4.9B | $5.1B |
| Debt incl. finance leases | $14.4B | $18.1B | $19.6B | $21.8B | $27.2B |
| Net debt / EBITDA | 1.2x | 1.3x | 1.3x | 1.4x | 1.8x |
| Debt / equity | 0.3x | 0.5x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 22.0x | 85.2x | 40.1x | 33.7x | 35.0x |
| Current ratio | 0.7x | 0.8x | 0.8x | 0.9x | 0.9x |
| Quick ratio | 0.6x | 0.7x | 0.7x | 0.8x | 0.7x |
| Total assets | $81.6B | $79.7B | $80.8B | $80.1B | $86.8B |
| Total liabilities | $36.2B | $38.3B | $39.7B | $40.7B | $47.1B |
| Shareholders' equity | $44.0B | $40.0B | $39.7B | $38.1B | $38.2B |
| Net debt (− = net cash) | $11.6B | $12.6B | $14.9B | $17.0B | $22.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$1.0M
2 insiders
Sold, 12 months
$12.9M
4 insiders
Of sales under plans
16%
$2.1M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Paula Rosput ReynoldsDirector | Bought | 100 | $479.12 | $0.0M | Form 4 |
| May 15, 2026 | Robert L WoodDirector | Sold | 4,335 | $506.39 | $2.2M | Form 4 |
| May 14, 2026 | Robert L WoodDirector | Sold | 880 | $508.76 | $0.4M | Form 4 |
| Mar 10, 2026 | Guillermo BicharaExec VP & Chief Legal Officer | Sold plan | 4,357 | $480.79 | $2.1M | Form 4 |
| Mar 10, 2026 | Sean DurbinEVP, Chief Operating Officer | Sold | 6,520 | $477.27 | $3.1M | Form 4 |
| Feb 24, 2026 | Binod PatwariSenior Vice President - APAC | Sold | 999 | $502.77 | $0.5M | Form 4 |
| Feb 17, 2026 | Guillermo BicharaExec VP & Chief Legal Officer | Sold | 9,455 | $480.45 | $4.5M | Form 4 |
| Dec 8, 2025 | Sanjiv LambaChief Executive Officer, Director | Bought | 2,520 | $396.68 | $1.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✕ | ✕ |
| Current ratio rose | ✓ | ✓ | ✕ |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | ✓ | ✕ | ✓ |
| F-score | 7 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | −3.9% | −3.6% | −4.1% |
| Altman Z'' | 1.86 | 2.13 | 2.06 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Linde LIN | $236.4B | 3.0% | 26.3% | 15.0% | 11.7% | 32.9x | 6 | |
| Air Products APD | $68.4B | −0.5% | −7.3% | −31.3% | −2.2% | — | 3 | Compare → |
| Nucor NUE | $59.0B | 5.7% | — | −0.6% | 8.6% | 20.6x | 6 | Compare → |
| Smurfit Westrock SW | $22.0B | 47.7% | 5.5% | 3.9% | 4.1% | 44.1x | 5 | Compare → |
| CRH CRH | $56.8B | 5.3% | 14.5% | 7.8% | 11.8% | 15.0x | 7 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $10.5B | $11.4B | $14.8B | $28.2B | $27.2B | $30.8B | $33.4B | $32.9B | $33.0B | $34.0B |
| Research and development | $92.0M | $93.0M | $113M | $184M | $152M | $143M | $143M | $146M | $150M | $147M |
| Operating income | $2.2B | $2.4B | $5.2B | $2.9B | $3.3B | $5.0B | $5.4B | $8.0B | $8.6B | $8.9B |
| Interest expense | $208M | $230M | $297M | $284M | $277M | $227M | $63.0M | $200M | $256M | $255M |
| Pretax income | $2.0B | $2.3B | $5.0B | $2.9B | $3.4B | $5.1B | $5.5B | $8.0B | $8.6B | $8.9B |
| Income tax | $551M | $1.0B | $817M | $769M | $847M | $1.3B | $1.4B | $1.8B | $2.0B | $2.0B |
| Net income | $1.5B | $1.2B | $4.4B | $2.3B | $2.5B | $3.8B | $4.1B | $6.2B | $6.6B | $6.9B |
| Diluted EPS | $5.21 | $4.32 | $13.11 | $4.19 | $4.71 | $7.33 | $8.23 | $12.59 | $13.62 | $14.61 |
| Diluted shares | 0.29B | 0.29B | 0.33B | 0.55B | 0.53B | 0.52B | 0.50B | 0.49B | 0.48B | 0.47B |
| Cash flow | ||||||||||
| Cash from operations | $2.8B | $3.0B | $3.7B | $6.1B | $7.4B | $9.7B | $8.9B | $9.3B | $9.4B | $10.4B |
| Capital expenditure | $1.5B | $1.3B | $1.9B | $3.7B | $3.4B | $3.1B | $3.2B | $3.8B | $4.5B | $5.3B |
| Free cash flow | $1.3B | $1.7B | $1.8B | $2.4B | $4.0B | $6.6B | $5.7B | $5.5B | $4.9B | $5.1B |
| Depreciation and amortization | $1.1B | $1.2B | $1.8B | $4.7B | $4.6B | $4.6B | $4.2B | $3.8B | $3.8B | $3.8B |
| Stock-based compensation | $39.0M | $59.0M | $62.0M | $95.0M | $133M | $128M | $107M | $141M | $160M | $164M |
| Acquisitions | $363M | $33.0M | $25.0M | $225M | $68.0M | $88.0M | $110M | $953M | $317M | $412M |
| Share buybacks | $228M | $12.0M | $599M | $2.7B | $2.5B | $4.6B | $5.2B | $4.0B | $4.5B | $4.6B |
| Dividends paid | $856M | $901M | $1.2B | $1.9B | $2.0B | $2.2B | $2.3B | $2.5B | $2.7B | $2.8B |
| Dividends and buybacks | $1.1B | $913M | $1.8B | $4.5B | $4.5B | $6.8B | $7.5B | $6.4B | $7.1B | $7.4B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $524M | $617M | $4.5B | $2.7B | $3.8B | $2.8B | $5.4B | $4.7B | $4.9B | $5.1B |
| Total debt | — | $9.0B | $15.3B | $14.0B | $16.2B | $14.2B | $17.9B | $19.4B | $21.6B | $27.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $149M | $163M | $176M | $156M | $193M | $204M | $214M |
| Current assets | — | $3.3B | $17.3B | $10.4B | $10.9B | $10.2B | $13.0B | $12.6B | $12.9B | $13.3B |
| Current liabilities | — | $3.3B | $13.0B | $12.2B | $13.7B | $13.6B | $16.5B | $15.7B | $14.5B | $15.2B |
| Inventory | $0.0M | $614M | $1.7B | $1.7B | $1.7B | $1.7B | $2.0B | $2.1B | $1.9B | $2.1B |
| Property and equipment, net | $11.2B | $11.8B | $29.7B | $29.1B | $28.7B | $26.0B | $23.5B | $24.6B | $24.8B | $28.3B |
| Total assets | — | $20.4B | $93.4B | $86.6B | $88.2B | $81.6B | $79.7B | $80.8B | $80.1B | $86.8B |
| Total liabilities | — | $13.9B | $36.3B | $35.0B | $38.6B | $36.2B | $38.3B | $39.7B | $40.7B | $47.1B |
| Shareholders' equity | $5.4B | $6.0B | $51.6B | $49.1B | $47.3B | $44.0B | $40.0B | $39.7B | $38.1B | $38.2B |
| Margins | ||||||||||
| Operating margin | 21.3% | 21.5% | 35.4% | 10.4% | 12.2% | 16.2% | 16.1% | 24.4% | 26.2% | 26.3% |
| EBITDA margin | 32.0% | 31.9% | 47.7% | 27.0% | 29.2% | 31.2% | 28.7% | 36.0% | 37.6% | 37.3% |
| Net margin | 14.2% | 11.0% | 29.5% | 8.1% | 9.2% | 12.4% | 12.4% | 18.9% | 19.9% | 20.3% |
| FCF margin | 12.6% | 15.2% | 11.9% | 8.6% | 14.8% | 21.6% | 17.1% | 16.8% | 14.9% | 15.0% |
| Returns | ||||||||||
| Return on capital | — | — | 10.6% | 3.3% | 4.0% | 6.3% | 7.2% | 11.3% | 11.8% | 11.7% |
| Return on capital employed | — | — | 10.8% | 3.8% | 4.5% | 7.0% | 8.2% | 12.5% | 13.2% | 13.0% |
| Return on equity | — | — | 15.2% | 4.5% | 5.2% | 8.4% | 9.9% | 15.6% | 16.9% | 18.1% |
| Return on assets | — | — | 7.7% | 2.5% | 2.9% | 4.5% | 5.1% | 7.7% | 8.2% | 8.3% |
| Growth | ||||||||||
| Revenue growth | — | 7.8% | 30.6% | 90.3% | −3.5% | 13.0% | 8.4% | −1.5% | 0.5% | 3.0% |
| Net income growth | — | −16.9% | 251.3% | −47.8% | 9.5% | 53.0% | 8.4% | 49.5% | 5.9% | 5.1% |
| EPS growth | — | −17.1% | 203.5% | −68.0% | 12.4% | 55.6% | 12.3% | 53.0% | 8.2% | 7.3% |
| FCF growth | — | 30.7% | 2.4% | 37.6% | 65.3% | 64.8% | −14.3% | −3.0% | −10.7% | 3.3% |
| Share count change | — | 0.5% | 15.6% | 63.2% | −2.6% | −1.8% | −3.4% | −2.3% | −2.1% | −2.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | — | 2.3x | 1.5x | 1.5x | 1.6x | 1.2x | 1.3x | 1.3x | 1.4x | 1.8x |
| Debt / equity | — | 1.5x | 0.3x | 0.3x | 0.3x | 0.3x | 0.5x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 10.8x | 10.6x | 17.7x | 10.3x | 12.0x | 22.0x | 85.2x | 40.1x | 33.7x | 35.0x |
| Current ratio | — | 1.0x | 1.3x | 0.9x | 0.8x | 0.7x | 0.8x | 0.8x | 0.9x | 0.9x |
| Quick ratio | — | 0.8x | 1.2x | 0.7x | 0.7x | 0.6x | 0.7x | 0.7x | 0.8x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 13.9% | 11.5% | 12.7% | 13.0% | 12.5% | 10.0% | 9.5% | 11.5% | 13.6% | 15.5% |
| Stock comp / revenue | 0.4% | 0.5% | 0.4% | 0.3% | 0.5% | 0.4% | 0.3% | 0.4% | 0.5% | 0.5% |
| Payouts / FCF | 81.9% | 52.8% | 99.7% | 186.7% | 111.3% | 102.4% | 132.0% | 116.7% | 144.9% | 145.7% |
| Quality scores | ||||||||||
| Piotroski F-score | — | — | — | 4.0 | 6.0 | 7.0 | 7.0 | 7.0 | 6.0 | 6.0 |
| Altman Z'' | — | 3.4 | 2.9 | 2.3 | 2.0 | 2.2 | 2.2 | 1.9 | 2.1 | 2.1 |
| Accruals ratio | — | — | 1.3% | −4.3% | −5.6% | −7.0% | −5.9% | −3.9% | −3.6% | −4.1% |
Source: SEC EDGAR XBRL filings (CIK 0001707925). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.